Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1460210rdf:typepubmed:Citationlld:pubmed
pubmed-article:1460210lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1460210lifeskim:mentionsumls-concept:C0035455lld:lifeskim
pubmed-article:1460210lifeskim:mentionsumls-concept:C0700624lld:lifeskim
pubmed-article:1460210lifeskim:mentionsumls-concept:C0242896lld:lifeskim
pubmed-article:1460210pubmed:issue6 Pt 2lld:pubmed
pubmed-article:1460210pubmed:dateCreated1993-1-12lld:pubmed
pubmed-article:1460210pubmed:abstractTextAnticholinergic agents have been used for nonallergic rhinitis expressly to control rhinorrhea. In allergic rhinitis, rhinorrhea can be extremely troublesome and unresponsive to traditional pharmacotherapeutic rhinitis treatments. Anticholinergic agents, through their specific ability to decrease nasal secretory response, should have beneficial effects for allergic rhinitis. In a recent trial ipratropium bromide at concentrations of 0.03% and 0.06% reduced rhinorrhea in allergic subjects without any demonstrable rebound effect. Therefore anticholinergic therapies may be a useful adjunct in controlling the rhinorrhea associated with allergic rhinitis.lld:pubmed
pubmed-article:1460210pubmed:languageenglld:pubmed
pubmed-article:1460210pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1460210pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1460210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1460210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1460210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1460210pubmed:statusMEDLINElld:pubmed
pubmed-article:1460210pubmed:monthDeclld:pubmed
pubmed-article:1460210pubmed:issn0091-6749lld:pubmed
pubmed-article:1460210pubmed:authorpubmed-author:GeorgitisJ...lld:pubmed
pubmed-article:1460210pubmed:issnTypePrintlld:pubmed
pubmed-article:1460210pubmed:volume90lld:pubmed
pubmed-article:1460210pubmed:ownerNLMlld:pubmed
pubmed-article:1460210pubmed:authorsCompleteYlld:pubmed
pubmed-article:1460210pubmed:pagination1071-6lld:pubmed
pubmed-article:1460210pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:meshHeadingpubmed-meshheading:1460210-...lld:pubmed
pubmed-article:1460210pubmed:year1992lld:pubmed
pubmed-article:1460210pubmed:articleTitleThe anticholinergic treatment of allergic perennial rhinitis.lld:pubmed
pubmed-article:1460210pubmed:affiliationDepartment of Pediatrics, Bowman Gray School of Medicine, Winston-Salem, NC 27157.lld:pubmed
pubmed-article:1460210pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1460210pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1460210pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1460210pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:1460210pubmed:publicationTypeMulticenter Studylld:pubmed